ArticlePharmacoepidemiology and drug safety2026

Applying a Pareto-Based Efficiency Frontier to Inform Value-Based Pricing for Gaucher Disease Therapies in Brazil.

Marcus Carvalho Borin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.